T86.290
Cardiac allograft vasculopathy
Clinical Classification Guidelines
Excludes Type 1
- atherosclerosis of coronary arteries (I25.75-, I25.76-, I25.81-)
Medical Intelligence & Overview
Cardiac allograft vasculopathy (CAV) is a serious complication that can occur after a heart transplant. It involves the progressive narrowing of the coronary arteries in the transplanted heart, which can impair blood flow and potentially lead to heart failure or other cardiac issues. Recognizing the signs, understanding the causes, and knowing the available management strategies are important for patients and caregivers dealing with this condition.
Causes & Symptoms
Clinical Causes: Rejection of the transplanted heart Immune response triggered by the body recognizing the transplant as foreign Chronic inflammation of blood vessel walls Infections that can contribute to inflammation Traditional risk factors such as high cholesterol, high blood pressure, and smoking Immunosuppressive medications that may influence vascular health
Key Symptoms: Often asymptomatic in early stages Chest pain or discomfort (angina) Shortness of breath Fatigue or weakness Symptoms related to decreased heart function Possible signs of heart failure such as swelling in legs or abdomen
Diagnostic & Treatment
Diagnosis Path: Regular echocardiograms to assess heart function Coronary angiography to visualize blockages or narrowing in coronary arteries Intravascular ultrasound (IVUS) for detailed imaging of blood vessel walls Non-invasive tests such as stress testing or coronary CT angiography Monitoring for changes in heart function through biopsy and blood tests
Treatment Protocols: Adjusting immunosuppressive therapy to reduce immune response Use of medications such as statins to lower cholesterol and stabilize blood vessels Antiplatelet drugs to prevent blood clots Management of associated risk factors like hypertension or diabetes Regular medical evaluations to detect early signs of progression Lifestyle modifications including a healthy diet, quitting smoking, and regular exercise In certain cases, revascularization procedures like angioplasty or coronary artery bypass grafting may be considered
Clinical Advice & FAQs
Billing Guidance
Is T86.290 a billable ICD-10 code?
Yes, T86.290 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T86.290?
Clinical documentation must specify the nature of Cardiac allograft vasculopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference